Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
A tertiary antimuscarinic amine with actions similar to atropine. Indicated as a urinary antispasmodic in bladder incontinence problems.
Oral administration 1 to 3 times a day.
Since the last update we have not found published data on its excretion in breastmilk.
Its pharmacokinetic data - large volume of distribution and high percentage of protein binding (AEMPS2016, Ortho2008) - make it unlikely that significant quantities will be transferred to breastmilk.
Its very low oral bioavailability (AEMPS2016, Ortho2008, Duchamos 1988) hinders transfer to infant plasma from breastmilk, except in premature infants and the immediate neonatal period when there may be greater intestinal permeability.
Milk production should be monitored, since anticholinergics can reduce milk production.
Possible anticholinergic symptoms (dry mouth, constipation...) in the infant should be monitored.
Expert authors consider the use of this medication to probably be safe during breastfeeding (Brigs 2017, Hale 2017 p 737).
Other similar anticholinergics, such as atropine, are considered by the American Academy of Pediatrics to usually be compatible with breastfeeding.
See below the information of this related product: